Northpond Ventures, SignalFire and P5 Health Ventures have helped San Francisco-based clinical trial software firm Hawthorne Effect complete a $20 million first formal funding round.
The round was led by Northpond Ventures, with participation from SignalFire and P5 Health Ventures.
The company intends to use the funds to accelerate growth and help scale operations.
Led by Jodi Akin, CEO and founder, Hawthorne Effect provides a solution for decentralizing clinical trials to alleviate key issues related to patient recruitment and retention via its tech-driven platform and expansive network of medical professionals. The company’s tech-driven platform, the Hawthorne Cloud, works with highly trained medical professionals, called Hawthorne Heroes, to deliver complete assessments whenever, wherever and however the trial and patient require.
Since launching in 2015, the solution has been used across more than 50 clinical trials. The company is actively engaged with more than 260 clinical sites and also runs trials as a single virtual site.
With the Covid positivity rate surging in bordering districts, the government has extended the countrywide restrictions for 10 more days to check virus transmission. The Cabinet Division yesterday issued a gazette notification to this effect, saying no social, political and religious gatherings will be allowed till June 16. [media type="image" id="940677" layout="portrait"
On Thursday, the authorities of Chapainawabganj Sadar Hospital increased the number of beds for Covid-19 patients to 30 from 20 to tackle the rush of patients. As it was not enough, the number of beds had to be raised to 50 yesterday. All the beds, however, got occupied by the evening, said Ahnaf Shahriar, a physician at the hospital's coronavirus unit. "We've more patients